The global oncology market is rapidly growing, with an expected value of over $470 billion by 2032. AbbVie Inc. is a leading player, making strides in cancer treatment development and acquisitions. Despite strong performance, its valuation remains reasonable, presenting potential for future growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing